National Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies - East of England, London and South East Coast

NHS framework agreement to supply aseptically prepared cytotoxic medicines and monoclonal antibodies - East of England, London and South East Coast. The framework may also be used by private sector contractors and agents working on behalf of the above. The framework agreement will commence on 1.7.2020 for a period of 12 months, with options to extend for a further 36 months.